EPISODE · May 29, 2026 · 1H
Fear Maxing: Health in the Headlines with Dr. Ben Schwartz
Ever feel overwhelmed by health headlines and wonder what's really true? The media loves to sensationalize, but Dr. Ben is here to set the record straight. We are si tired of fear-mongering headlines and want real, science-backed info, so we dive into everything — hantavirus on cruise ships, the mysterious rise of alpha-gal allergies, and why we should be cautious with big pharma's latest elixirs. The truth? Most of these threats are highly unlikely to impact you personally—so don’t hit that panic button yet.The key? Focus on your root health — a strong immune system, good gut health, and informed choices. Your body is resilient and designed to thrive when supported—not scared into submission.Timestamps: 00:00 - Welcome and episode overview on health headlines 02:37 - The real scoop on hantavirus transmission and risk 05:32 - Will hantavirus or Ebola become a pandemic? Dr. Ben’s epidemiology insights 08:36 - The return of Ebola headlines and travel restrictions 12:49 - The Netflix “poop cruise” and viral fear narratives 16:21 - The rise of alpha-gal syndrome and tick-borne allergies 22:14 - Debunking conspiracy theories on Lyme disease and bioweapons 26:55 - Off-label use of antihistamines for PMS and hormonal issues 33:41 - The gut-brain axis, histamine, and hormone interplay 36:25 - Stress, cortisol, and visceral fat's role in aging 40:33 - Fiber’s benefits for microbiome, blood sugar, and hormone health 43:00 - The controversy around GLP-1 medications like Ozempic and long-term safety 55:53 - The new classification of PCOS to PMOS and hormonal health in women 60:00 - Practical steps: sleep, root cause focus, and cautious supplement useResources & Links:Benton IntegrativeAlpha-Gal Syndrome overviewWonderSide Insect Repellentwww.crowdhealth.comConnect with Dr. Ben Schwartz:LinkedInWebsite
NOW PLAYING
Fear Maxing: Health in the Headlines with Dr. Ben Schwartz
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m